These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11797109)

  • 21. Circulating bone marrow-derived endothelial progenitor cells: characterization, mobilization, and therapeutic considerations in malignant disease.
    Dome B; Dobos J; Tovari J; Paku S; Kovacs G; Ostoros G; Timar J
    Cytometry A; 2008 Mar; 73(3):186-93. PubMed ID: 18000872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A review of angiogenesis and anti-angiogenic therapy in hematologic malignancies.
    Rajkumar SV; Mesa RA; Tefferi A
    J Hematother Stem Cell Res; 2002 Feb; 11(1):33-47. PubMed ID: 11847002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiogenesis and gliomas: current issues and development of surrogate markers.
    Jouanneau E
    Neurosurgery; 2008 Jan; 62(1):31-50; discussion 50-2. PubMed ID: 18300890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of angiogenesis in the biology and therapy of myelodysplastic syndromes.
    Aguayo A
    Curr Hematol Rep; 2004 May; 3(3):184-91. PubMed ID: 15087066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?
    Rafii S; Lyden D; Benezra R; Hattori K; Heissig B
    Nat Rev Cancer; 2002 Nov; 2(11):826-35. PubMed ID: 12415253
    [No Abstract]   [Full Text] [Related]  

  • 26. Antiangiogenic therapy in hematologic malignancies.
    Moehler TM; Hillengass J; Goldschmidt H; Ho AD
    Curr Pharm Des; 2004; 10(11):1221-34. PubMed ID: 15078137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor angiogenesis: biology and therapeutic prospects.
    Harris SR; Thorgeirsson UP
    In Vivo; 1998; 12(6):563-70. PubMed ID: 9891218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A surrogate marker to monitor angiogenesis at last.
    Schneider M; Tjwa M; Carmeliet P
    Cancer Cell; 2005 Jan; 7(1):3-4. PubMed ID: 15652744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2.
    Oh HK; Ha JM; O E; Lee BH; Lee SK; Shim BS; Hong YK; Joe YA
    Cancer Res; 2007 May; 67(10):4851-9. PubMed ID: 17510415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiogenesis in hematologic malignancies and its clinical implications.
    Yang R; Han ZC
    Int J Hematol; 2002 Apr; 75(3):246-56. PubMed ID: 11999351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Managing tumor angiogenesis: lessons from VEGF-resistant tumors and wounds.
    Cuevas I; Boudreau N
    Adv Cancer Res; 2009; 103():25-42. PubMed ID: 19854351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of angiogenesis in hematologic malignancies.
    Stasi R; Amadori S
    J Hematother Stem Cell Res; 2002 Feb; 11(1):49-68. PubMed ID: 11847003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hematopoietic cancer and angiogenesis.
    Ribatti D; Scavelli C; Roccaro AM; Crivellato E; Nico B; Vacca A
    Stem Cells Dev; 2004 Oct; 13(5):484-95. PubMed ID: 15588506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Role of angiogenesis in the growth and progression of tumors. Treatment with angiogenesis inhibitors: from promising results in experimental animal models to the reality of clinical use].
    Plavetić ND; Letilović T; Vrbanec D
    Lijec Vjesn; 2003; 125(9-10):260-5. PubMed ID: 15038217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma.
    Pang R; Poon RT
    Cancer Lett; 2006 Oct; 242(2):151-67. PubMed ID: 16564617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiogenesis in the bone marrow of patients with breast cancer.
    Chavez-Macgregor M; Aviles-Salas A; Green D; Fuentes-Alburo A; Gómez-Ruiz C; Aguayo A
    Clin Cancer Res; 2005 Aug; 11(15):5396-400. PubMed ID: 16061853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiogenesis and the role of bone marrow endothelial cells in haematological malignancies.
    De Raeve H; Van Marck E; Van Camp B; Vanderkerken K
    Histol Histopathol; 2004 Jul; 19(3):935-50. PubMed ID: 15168356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiogenesis in multiple myeloma.
    Jakob C; Sterz J; Zavrski I; Heider U; Kleeberg L; Fleissner C; Kaiser M; Sezer O
    Eur J Cancer; 2006 Jul; 42(11):1581-90. PubMed ID: 16797965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Granulocyte colony-stimulating factor promotes tumor angiogenesis via increasing circulating endothelial progenitor cells and Gr1+CD11b+ cells in cancer animal models.
    Okazaki T; Ebihara S; Asada M; Kanda A; Sasaki H; Yamaya M
    Int Immunol; 2006 Jan; 18(1):1-9. PubMed ID: 16352631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased bone marrow microvascular density in haematological malignancies is associated with differential regulation of angiogenic factors.
    Negaard HF; Iversen N; Bowitz-Lothe IM; Sandset PM; Steinsvik B; Ostenstad B; Iversen PO
    Leukemia; 2009 Jan; 23(1):162-9. PubMed ID: 18800145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.